⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7262114 | 0.77 | NFKB1 (0.41) | — | |
| SCHEMBL17715369 | 0.74 | NFKB1 (0.31) | — | |
| SCHEMBL2840228 | 0.72 | — | — | |
| SCHEMBL2840229 | 0.72 | — | — | |
| SCHEMBL28486037 | 0.72 | — | — | |
| SCHEMBL16542717 | 0.72 | — | — | |
| Hydrochloric Acid SCHEMBL28847875 | 0.70 | — | — | |
| SCHEMBL28601965 | 0.69 | — | — | |
| SCHEMBL3915521 | 0.69 | — | — | |
| SCHEMBL28800558 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112006978-B | Targeting chitosan nano silver gel and preparation method and application thereof | 大连民族大学 | 2023-04-28 | — | — | CN | claimed |
| CN-112006978-A | Targeted chitosan nano-silver gel and preparation method and application thereof | 大连民族大学 | 2020-12-01 | — | — | CN | claimed |
| CN-109071634-A | Antibody coupling matter and its preparation and application | R.P.谢勒技术有限责任公司 | 2018-12-21 | — | — | CN | claimed |
| WO-2018169953-A1 | ANTIBODY CONJUGATES AND METHODS OF MAKING AND USING THE SAME | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2018-09-20 | — | — | WO | claimed |
| WO-2017189432-A1 | ANTIBODY CONJUGATES AND METHODS OF MAKING AND USING THE SAME | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2017-11-02 | — | — | WO | claimed |
| US-20170306300-A1 | ANTIBODY CONJUGATES AND METHODS OF MAKING AND USING THE SAME | ARES CAPITAL CORPORATION, AS COLLATERAL AGENT | 2017-10-26 | — | — | US | claimed |
| US-20250381290-A1 | Antibody Conjugates and Methods of Making and Using the Same | SCHERER TECHNOLOGIES LLC R P (US) | 2025-12-18 | — | — | US | disclosed |
| US-12296021-B2 | Antibody conjugates and methods of making and using the same | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2025-05-13 | — | — | US | disclosed |
| US-20240101975-A1 | Antibody Conjugates and Methods of Making and Using the Same | ARES CAPITAL CORPORATION, AS COLLATERAL AGENT | 2024-03-28 | — | — | US | disclosed |
| US-11788066-B2 | Antibody conjugates and methods of making and using the same | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2023-10-17 | — | — | US | disclosed |
| US-20230235079-A1 | Antibody Conjugates and Methods of Making and Using the Same | R.P. SCHERER TECHNOLOGIES, LLC | 2023-07-27 | — | — | US | disclosed |
| CN-112006978-B | Targeting chitosan nano silver gel and preparation method and application thereof | 大连民族大学 | 2023-04-28 | — | — | CN | disclosed |
| US-11466096-B2 | Antibody conjugates and methods of making and using the same | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2022-10-11 | — | — | US | disclosed |
| US-6413962-B1 | ANESTHESIA AND TEMPERATURES REDUCTION; ALPHA-ADRENOCEPTOR AGONIST; RESTORATIVE TO CENTRAL NERVOUS SYSTEM, ESPECIALLY MOTOR AND SENSORY FUNCTIONAL LOSSES FROM TRAMATIC SPINAL CORD INJURIES; ANTISPASTICS; NONSEDATIVE; SIDE EFFECT REDUCTION | NAFTCHI N ERIC (US) | 2002-07-02 | — | — | US | disclosed |
| WO-1996026190-A1 | INTEGRIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1996-08-29 | — | — | WO | disclosed |
| US-H1427-H | Treating cancer by administering flavonoid immunomodulator with interleukin-2 | BRIET PHILLIPE (FR) | 1995-04-04 | — | — | US | disclosed |
| EP-0341104-B1 | Substituted flavonoid compounds, their salts, their manufacture and medicines containing these materials | MERCK PATENT GMBH (DE) | 1993-12-29 | — | — | EP | disclosed |
| US-5116954-A | Antitumor agents | LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) | 1992-05-26 | — | — | US | disclosed |
| EP-0341104-A2 | Substituted flavonoid compounds, their salts, their manufacture and medicines containing these materials | MERCK PATENT GmbH (DE) | 1989-11-08 | — | — | EP | disclosed |
| US-4028380-A | Hydrazino-imidazole derivatives | AKZONA INCORPORATED (US) | 1977-06-07 | — | — | US | disclosed |